Two studies have examined the effects of CRHR1 antagonist verucerfont (formerly GSK561679) on alcohol craving (Schwandt et al., 2016) and PTSD (Dunlop et al., 2017), with both studies finding little effect. The gene discussed is CRHR1; the disease is post-traumatic stress disorder.